Related Experiment Video
Updated: Jul 12, 2025
08:22
Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
Published on: December 22, 2023
592
Chemical Composition, Functional and Anticancer Properties of Carrot
Luigi Mandrich1, Antonia Valeria Esposito2, Silvio Costa2
1Research Institute on Terrestrial Ecosystems-IRET-CNR, Via Pietro Castellino 111, 80131 Naples, Italy.
Molecules (Basel, Switzerland)
|October 28, 2023
Summary
Daucus carota, including edible and wild carrots, contains bioactive compounds with anticancer properties. This review explores their chemical composition and potential for developing new cancer therapies.
Area of Science:
- Phytochemistry
- Pharmacology
- Oncology
Background:
- Plants are a crucial source of anticancer drugs.
- Daucus carota (carrot) exhibits diverse health benefits.
- Both edible (D. carota L. subsp. Sativus) and wild (D. carota L. subsp. Carrot) subspecies possess medicinal properties.
Purpose of the Study:
- To review the chemical composition and functional properties of Daucus carota subspecies.
- To identify compounds with anticancer characteristics in both edible and wild carrots.
- To discuss the potential of these compounds in novel anticancer therapeutic strategies.
Main Methods:
- Literature review of Daucus carota chemical composition.
- Analysis of functional properties of edible and wild carrot subspecies.
- Identification and discussion of anticancer compounds.
Main Results:
- Edible carrots are rich in carotenoids and dietary fiber.
- Wild carrots have traditional uses for gastric ulcers, diabetes, and muscle pain.
- Specific compounds from both subspecies demonstrate anticancer potential.
Conclusions:
- Daucus carota is a promising source for anticancer drug development.
- Further research into carrot-derived compounds can lead to novel therapeutic strategies.
- Both edible and wild carrot subspecies warrant investigation for their oncological applications.
Related Concept Videos
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:46Electron Transport Chain: Complex I and II
14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.2K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K